Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

NattoPharma prepares new vitamin K analogues

Sep. 2, 2011

New 11-beta-HSD1 inhibitor has potent preclinical activity

Sep. 2, 2011

Autologous hematopoietic stem cell therapy successfully treats children with ADA-SCID

Sep. 2, 2011

Mitsubishi Tanabe files for approval of tenegliptin in Japan

Sep. 1, 2011

British company patents novel neuropeptide Y2 receptor ligands

Sep. 1, 2011

Johnson & Johnson presents potential novel approach to treat diabetes and obesity

Sep. 1, 2011

Tianjin Institute of Pharmaceutical Research discloses new agents for diabetes

Sep. 1, 2011

Bionovo reports data from Menerba trial in postmenopausal women

Aug. 31, 2011

Aeterna Zentaris reports encouraging phase III data on AEZS-130

Aug. 31, 2011

Preclinical program of afamelanotide for erythropoietic protoporphyria completed

Aug. 31, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...